Data sources for drug utilization research in Latin American countries—A cross-national study: DASDUR-LATAM study
Data sources for drug utilization research in Latin American countries—A cross-national study: DASDUR-LATAM study
Data
2022
Autores
Lopes, Luciane C.
Salas, Maribel
Osorio-de-Castro, Claudia Garcia Serpa
Leal, Lisiane Freitas
Doubova, Svetlana V.
Cañás, Martín
Dreser, Anahi
Acosta, Angela
Baldoni, Andre Oliveira
Bergamaschi, Cristiane de Cássia
Journal Title
Journal ISSN
Volume Title
Publisher
Pharmacoepidemiology and Drug Safety
Resumo
Purpose: Drug utilization research (DUR) contributes to inform policymaking and to
strengthen health systems. The availability of data sources is the first step for con-
ducting DUR. However, documents that systematize these data sources in Latin
American (LatAm) countries are not known. We compiled the potential data sources
for DUR in the LatAm region.
Methods: A network of DUR experts from nine LatAm countries was assembled and
experts conducted: (i) a website search of the government, academic, and private
health institutions; (ii) screening of eligible data sources, and (iii) liaising with national
experts in pharmacoepidemiology (via an online survey). The data sources were char-
acterized by accessibility, geographic granularity, setting, sector of the data, sources
and type of the data. Descriptive analyses were performed.
Results: We identified 125 data sources for DUR in nine LatAm countries. Thirty-
eight (30%) of them were publicly and conveniently available; 89 (71%) were accessi-
ble with limitations, and 18 (14%) were not accessible or lacked clear rules for data
access. From the 125 data sources, 76 (61%) were from the public sector only;
46 (37%) were from pharmacy records; 43 (34%) came from ambulatory settings and;
85 (68%) gave access to individual patient-level data.
Conclusions: Although multiple sources for DUR are available in LatAm countries,
the accessibility is a major challenge. The procedures for accessing DUR data should
be transparent, feasible, affordable, and protocol-driven. This inventory could permit
a comparison of drug utilization between countries identifying potential medication-
related problems that need further exploration.
Description
Palavras-chave
cross-national, drug utilization research, Latin America, pharmacoepidemiology
Citação
Lopes LC, Salas M, Osorio-de-Castro CGS, Leal LF, Doubova SV, Cañás M, Dreser A, Acosta A, Baldoni AO, de Cássia Bergamaschi C, Mota DM, Gómez-Galicia DL, Sepúlveda-Viveros D, Delgado EN, da Costa Lima E, Chandia FV, Ferre F, Marin GH, Olmos I, Zimmermann IR, Fulone I, Roldán-Saelzer J, Sánchez-Salgado JC, Castro-Pastrana LI, de Souza LJC, Beltrán MM, Silva MT, Mena MB, de França Fonteles MM, Urtasun MA, Tarapués M, Hernández PG, Medero N, Herrera-Comoglio R, Barberato-Filho S, Galvão TF, Luiza VL, Santa-Ana-Tellez Y, Rodríguez-Tanta Y, Elseviers M. Data sources for drug utilization research in Latin American countries-A cross-national study: DASDUR-LATAM study. Pharmacoepidemiol Drug Saf. 2022 Mar;31(3):343-352. doi: 10.1002/pds.5404.